Total Payments
$8,262
2024 Payments
$1,555
Companies
40
Transactions
440
Medicare Patients
7,077
Medicare Billing
$967,868
Payment Breakdown by Category
Food & Beverage$7,907 (95.7%)
Education$183.78 (2.2%)
Other$171.75 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,907 | 419 | 95.7% |
| Education | $183.78 | 20 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $171.75 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,420 | 90 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,110 | 54 | $0 (2024) |
| ABBVIE INC. | $768.56 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $663.81 | 35 | $0 (2023) |
| GlaxoSmithKline, LLC. | $462.26 | 19 | $0 (2024) |
| PFIZER INC. | $450.77 | 30 | $0 (2024) |
| Amgen Inc. | $379.02 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $355.88 | 16 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $313.07 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $274.69 | 28 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,555 | 70 | AstraZeneca Pharmaceuticals LP ($429.94) |
| 2023 | $1,170 | 48 | AbbVie Inc. ($302.79) |
| 2022 | $846.44 | 34 | ABBVIE INC. ($258.65) |
| 2021 | $903.88 | 50 | Novo Nordisk Inc ($193.63) |
| 2020 | $1,406 | 68 | GlaxoSmithKline, LLC. ($258.49) |
| 2019 | $951.64 | 59 | Novo Nordisk Inc ($227.24) |
| 2018 | $591.52 | 38 | Novo Nordisk Inc ($189.73) |
| 2017 | $837.24 | 73 | Novo Nordisk Inc ($259.88) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Cardio-renal | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Obesity | ||||||
| 08/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Inflammation | ||||||
| 08/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,446 | 2,730 | $509,634 | $200,897 |
| 2022 | 24 | 1,931 | 3,713 | $684,170 | $260,442 |
| 2021 | 23 | 1,869 | 3,519 | $647,519 | $255,495 |
| 2020 | 24 | 1,831 | 3,573 | $655,475 | $251,034 |
Total Patients
7,077
Total Services
13,535
Medicare Billing
$967,868
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 431 | $95,251 | $35,282 | 37.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 132 | 170 | $69,870 | $22,766 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 373 | $56,323 | $18,883 | 33.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 277 | $40,996 | $17,320 | 42.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 87 | 261 | $36,540 | $15,430 | 42.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 143 | $30,173 | $13,484 | 44.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 86 | 93 | $31,527 | $13,176 | 41.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 111 | 145 | $31,610 | $13,127 | 41.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 94 | 102 | $21,930 | $10,640 | 48.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 221 | $21,879 | $9,965 | 45.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $13,924 | $7,622 | 54.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 26 | $12,220 | $5,268 | 43.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 45 | 45 | $6,750 | $3,233 | 47.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 26 | 34 | $6,324 | $2,883 | 45.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $5,235 | $2,476 | 47.3% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 16 | 16 | $7,072 | $2,456 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,678 | $1,857 | 32.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 115 | 173 | $5,190 | $1,453 | 28.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $2,350 | $1,417 | 60.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 21 | 24 | $2,592 | $959.56 | 37.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $3,600 | $708.54 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 26 | $1,600 | $288.25 | 18.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 20 | $1,000 | $201.88 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 491 | $108,511 | $39,796 | 36.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 174 | 631 | $88,340 | $34,204 | 38.7% |
About Dr. Alok Rustogi, MD
Dr. Alok Rustogi, MD is a Adolescent Medicine healthcare provider based in Potomac Falls, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730116575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alok Rustogi, MD has received a total of $8,262 in payments from pharmaceutical and medical device companies, with $1,555 received in 2024. These payments were reported across 440 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,907).
As a Medicare-enrolled provider, Rustogi has provided services to 7,077 Medicare beneficiaries, totaling 13,535 services with total Medicare billing of $967,868. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Adolescent Medicine
- Location Potomac Falls, VA
- Active Since 06/27/2006
- Last Updated 02/27/2008
- Taxonomy Code 207RA0000X
- Entity Type Individual
- NPI Number 1730116575
Products in Payments
- Ozempic (Drug) $788.20
- FARXIGA (Drug) $746.06
- QULIPTA (Drug) $446.91
- VRAYLAR (Drug) $381.89
- Otezla (Drug) $379.02
- SOLIQUA 100/33 (Biological) $322.89
- XARELTO (Drug) $317.52
- Kerendia (Drug) $313.07
- Victoza (Drug) $301.03
- TRELEGY ELLIPTA (Drug) $216.26
- AIRSUPRA (Drug) $197.15
- CHANTIX (Drug) $191.02
- TRADJENTA (Drug) $171.90
- ENGERIX-B (Biological) $171.75
- APTIOM (Drug) $158.90
- Vascepa (Drug) $133.33
- KYNMOBI (Drug) $127.94
- SOLIQUA (Drug) $125.76
- ELIQUIS (Drug) $124.63
- Rybelsus (Drug) $124.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.